Small interfering peptide (siP) for in vivo examination of the developing lung interactonome.
about
CFTR: a hub for kinases and crosstalk of cAMP and Ca2+Cystic fibrosis transmembrane regulator fragments with the Phe508 deletion exert a dual allosteric control over the master kinase CK2.CFTR mutations altering CFTR fragmentation.Strategies for identifying synthetic peptides to act as inhibitors of NADPH oxidases, or "all that you did and did not want to know about Nox inhibitory peptides".Epithelial IgG and its relationship to the loss of F508 in the common mutant form of the cystic fibrosis transmembrane conductance regulator.
P2860
Small interfering peptide (siP) for in vivo examination of the developing lung interactonome.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Small interfering peptide (siP ...... developing lung interactonome.
@en
type
label
Small interfering peptide (siP ...... developing lung interactonome.
@en
prefLabel
Small interfering peptide (siP ...... developing lung interactonome.
@en
P2093
P2860
P356
P1476
Small interfering peptide (siP ...... developing lung interactonome.
@en
P2093
Anil Mehta
Avinash Chander
Erin Killeen
J Craig Cohen
Janet E Larson
Kate J Treharne
Ken-Ichi Takemaru
P2860
P304
P356
10.1002/DVDY.21834
P577
2009-02-01T00:00:00Z